AUD 0.39
(-4.88%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 | 10.28 Thousand AUD | 100.32% |
2023 | -3.21 Million AUD | 43.74% |
2022 | -5.71 Million AUD | -14496.19% |
2021 | -39.16 Thousand AUD | 85.76% |
2020 | -275.05 Thousand AUD | -135.77% |
2019 | 769.03 Thousand AUD | 145.1% |
2018 | 313.75 Thousand AUD | 213.63% |
2017 | 100.04 Thousand AUD | -66.65% |
2016 | 300 Thousand AUD | 0.0% |
2015 | - AUD | 0.0% |
2014 | - AUD | 0.0% |
2013 | - AUD | 0.0% |
2012 | - AUD | 0.0% |
2011 | - AUD | -100.0% |
2010 | 34.25 Thousand AUD | 0.0% |
2009 | - AUD | 0.0% |
2008 | - AUD | -100.0% |
2007 | 24.92 Million AUD | 35494.25% |
2006 | 70.03 Thousand AUD | -82.1% |
2005 | 391.28 Thousand AUD | 8.77% |
2004 | 359.75 Thousand AUD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q4 | -283.08 Thousand AUD | 0.0% |
2024 Q2 | -1.1 Million AUD | 0.0% |
2024 FY | -1.38 Million AUD | 56.84% |
2023 Q4 | -1.18 Million AUD | 0.0% |
2023 FY | -3.21 Million AUD | 43.74% |
2023 Q2 | -2.03 Million AUD | 0.0% |
2022 FY | -5.71 Million AUD | -14496.19% |
2022 Q2 | -1.65 Million AUD | 0.0% |
2022 Q4 | -4.05 Million AUD | 0.0% |
2021 Q2 | 90.5 Thousand AUD | 0.0% |
2021 FY | -39.16 Thousand AUD | 85.76% |
2021 Q4 | 111.23 Thousand AUD | 0.0% |
2020 Q4 | - AUD | 0.0% |
2020 Q2 | - AUD | 0.0% |
2020 FY | -275.05 Thousand AUD | -135.77% |
2019 Q4 | 769.03 Thousand AUD | 0.0% |
2019 FY | 769.03 Thousand AUD | 145.1% |
2019 Q2 | - AUD | 0.0% |
2018 Q4 | 235.42 Thousand AUD | 0.0% |
2018 FY | 313.75 Thousand AUD | 213.63% |
2018 Q2 | 78.32 Thousand AUD | 0.0% |
2017 FY | 100.04 Thousand AUD | -66.65% |
2017 Q4 | 100.04 Thousand AUD | 0.0% |
2017 Q2 | - AUD | 0.0% |
2016 Q4 | 50 Thousand AUD | 0.0% |
2016 Q1 | - AUD | 0.0% |
2016 Q2 | 250 Thousand AUD | 0.0% |
2016 Q3 | - AUD | -100.0% |
2016 FY | 300 Thousand AUD | 0.0% |
2015 Q3 | - AUD | 0.0% |
2015 Q1 | - AUD | 0.0% |
2015 Q4 | - AUD | 0.0% |
2015 Q2 | - AUD | 0.0% |
2015 FY | - AUD | 0.0% |
2014 Q1 | - AUD | 0.0% |
2014 Q2 | - AUD | 0.0% |
2014 Q3 | - AUD | 0.0% |
2014 Q4 | - AUD | 0.0% |
2014 FY | - AUD | 0.0% |
2013 Q3 | - AUD | 0.0% |
2013 Q1 | - AUD | 0.0% |
2013 Q2 | - AUD | 0.0% |
2013 FY | - AUD | 0.0% |
2013 Q4 | - AUD | 0.0% |
2012 FY | - AUD | 0.0% |
2012 Q3 | - AUD | 0.0% |
2012 Q2 | - AUD | 0.0% |
2012 Q1 | - AUD | 0.0% |
2012 Q4 | - AUD | 0.0% |
2011 Q4 | - AUD | 0.0% |
2011 Q3 | - AUD | 0.0% |
2011 FY | - AUD | -100.0% |
2011 Q2 | - AUD | -100.0% |
2011 Q1 | 8562.50 AUD | 0.0% |
2010 Q4 | 8562.50 AUD | 0.0% |
2010 Q3 | 8562.50 AUD | 0.0% |
2010 FY | 34.25 Thousand AUD | 0.0% |
2010 Q2 | 8562.50 AUD | 0.0% |
2010 Q1 | - AUD | 0.0% |
2009 Q2 | - AUD | 0.0% |
2009 Q1 | - AUD | 0.0% |
2009 Q4 | - AUD | 0.0% |
2009 FY | - AUD | 0.0% |
2009 Q3 | - AUD | 0.0% |
2008 FY | - AUD | -100.0% |
2008 Q4 | - AUD | 0.0% |
2008 Q3 | - AUD | 0.0% |
2008 Q1 | 6.23 Million AUD | 0.0% |
2008 Q2 | - AUD | -100.0% |
2007 FY | 24.92 Million AUD | 35494.25% |
2007 Q1 | 17.5 Thousand AUD | 0.0% |
2007 Q2 | 6.23 Million AUD | 35495.77% |
2007 Q3 | 6.23 Million AUD | 0.0% |
2007 Q4 | 6.23 Million AUD | -0.0% |
2006 FY | 70.03 Thousand AUD | -82.1% |
2006 Q2 | 17.5 Thousand AUD | -82.1% |
2006 Q3 | 17.5 Thousand AUD | 0.0% |
2006 Q1 | 97.82 Thousand AUD | 0.0% |
2006 Q4 | 17.5 Thousand AUD | 0.0% |
2005 Q2 | 97.82 Thousand AUD | 8.77% |
2005 Q1 | 89.93 Thousand AUD | 0.0% |
2005 Q4 | 97.82 Thousand AUD | 0.0% |
2005 Q3 | 97.82 Thousand AUD | 0.0% |
2005 FY | 391.28 Thousand AUD | 8.77% |
2004 Q4 | 89.93 Thousand AUD | 0.0% |
2004 FY | 359.75 Thousand AUD | 0.0% |
2004 Q3 | 89.93 Thousand AUD | 0.0% |
2004 Q2 | 89.93 Thousand AUD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
AdAlta Limited | 1.5 Million AUD | 99.318% |
Acrux Limited | -1.28 Million AUD | 100.801% |
Botanix Pharmaceuticals Limited | -6.55 Million AUD | 100.157% |
BTC Health Limited | 16.36 Thousand AUD | 37.139% |
Chimeric Therapeutics Limited | 7.45 Million AUD | 99.862% |
Clarity Pharmaceuticals Ltd | 11.5 Million AUD | 99.911% |
Clinuvel Pharmaceuticals Limited | 78.09 Million AUD | 99.987% |
Biome Australia Limited | 7.66 Million AUD | 99.866% |
Hexima Limited | - AUD | -Infinity% |
Immutep Limited | 1.44 Million AUD | 99.288% |
Memphasys Limited | 1606.00 AUD | -540.349% |
Neuren Pharmaceuticals Limited | 205.17 Million AUD | 99.995% |
Noxopharm Limited | -534.81 Thousand AUD | 101.923% |
Prescient Therapeutics Limited | 3.71 Million AUD | 99.723% |
Race Oncology Limited | 1.38 Million AUD | 99.26% |
Radiopharm Theranostics Limited | -21.3 Million AUD | 100.048% |
Starpharma Holdings Limited | 7.65 Million AUD | 99.866% |
Tissue Repair Ltd | 150.51 Thousand AUD | 93.167% |
Biotron Limited | -40.49 Thousand AUD | 125.394% |
Alterity Therapeutics Limited | 3.8 Million AUD | 99.73% |
CSL Limited | 15.28 Billion AUD | 100.0% |
EZZ Life Science Holdings Limited | 50.94 Million AUD | 99.98% |
Anatara Lifesciences Ltd | -748.91 Thousand AUD | 101.373% |
Bio-Gene Technology Limited | -301.44 Thousand AUD | 103.412% |
Patrys Limited | 1.39 Million AUD | 99.262% |
Orthocell Limited | 3.68 Million AUD | 99.721% |
Imugene Limited | -5.83 Million AUD | 100.176% |
PYC Therapeutics Limited | 22.05 Million AUD | 99.953% |
Proteomics International Laboratories Limited | -1.12 Million AUD | 100.916% |
Cynata Therapeutics Limited | 2.31 Million AUD | 99.556% |
Arovella Therapeutics Limited | -25.97 Thousand AUD | 139.586% |
Nanollose Limited | -348.95 Thousand AUD | 102.947% |
Invex Therapeutics Ltd | 1.21 Million AUD | 99.152% |
NeuroScientific Biopharmaceuticals Limited | -91.33 Thousand AUD | 111.259% |
Amplia Therapeutics Limited | 4.01 Million AUD | 99.744% |
Island Pharmaceuticals Limited | 1.25 Million AUD | 99.178% |
Nyrada Inc. | -5164.07 AUD | 299.145% |
Telix Pharmaceuticals Limited | 308.5 Million AUD | 99.997% |
Dimerix Limited | 583.47 Thousand AUD | 98.237% |
PharmAust Limited | -1641.00 AUD | 726.691% |
AnteoTech Limited | 460.39 Thousand AUD | 97.766% |
Paradigm Biopharmaceuticals Limited | 56.81 Thousand AUD | 81.898% |
Recce Pharmaceuticals Ltd | -366.76 Thousand AUD | 102.804% |
Avecho Biotechnology Limited | -43.79 Thousand AUD | 123.482% |
Actinogen Medical Limited | 9.93 Million AUD | 99.896% |
Immuron Limited | 3.33 Million AUD | 99.692% |
Argenica Therapeutics Limited | 2.59 Million AUD | 99.604% |